EMIT 2000 PROCAINAMIDE ASSAY, MODEL OSR4K229— 510(k) K010812

Name: FDA 510(k) clearance K010812
Creator: U.S. Food and Drug Administration
Published: 2001-04-13

Substantially Equivalent

Syva Co., Dade Behring, Inc.

FDA 510(k) clearance K010812 for EMIT 2000 PROCAINAMIDE ASSAY, MODEL OSR4K229, Substantially Equivalent on 2001-04-13. Applicant: Syva Co., Dade Behring, Inc.. Device class: 2.

Clearance details

Applicant: Syva Co., Dade Behring, Inc.
Product code: Code LAR
Device class: Class 2
Regulation: 21 CFR 862.3320
Advisory panel: Clinical Toxicology
Date received: 2001-03-19
Decision date: 2001-04-13
Decision: Substantially Equivalent
Clearance type: Special
Location: San Jose, CA, US

Download summary PDF View on FDA.gov ↗

Recent devices under product code LAR

view all

K060773 — ONLINE TDM PROCAINAMIDE2006-08-23
K032573 — DIMENSION PROCAINAMIDE (PROC) FLEX REAGENT CARTRIDGE METHOD, MODEL DF1102003-10-31
K971716 — PROCAINAMIDE ASSAY FOR THE BAYER IMMUNO 1 SYSTEM1997-06-27
K963306 — CEDIA N-ACETYLPROCAINAMIDE ASSAY1996-10-29
K962099 — CEDIA PROCAINAMIDE ASSAY1996-08-27

More clearances from Syva Co., Dade Behring, Inc.

view all

K011920 — EMIT 2000 DIGOXIN ASSAY, MODEL OSR4H2292001-07-02
K011620 — EMIT 2000 N-ACETYLPROCAINAMIDE ASSAY, MODEL OSR4N2292001-06-18
K011605 — EMIT 2000 QUINIDINE ASSAY, MODEL OSR4Q2292001-06-12
K011300 — EMIT II PLUS CANNABINOID ASSAY, MODEL OSR9N2292001-05-17
K011306 — EMIT II PLUS BENZODIAZEPINE ASSAY, MODEL 0SR9F2292001-05-16

Data sourced from openFDA. This site is unofficial and independent of the FDA.